GB202013912D0 - Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 - Google Patents
Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2Info
- Publication number
- GB202013912D0 GB202013912D0 GBGB2013912.7A GB202013912A GB202013912D0 GB 202013912 D0 GB202013912 D0 GB 202013912D0 GB 202013912 A GB202013912 A GB 202013912A GB 202013912 D0 GB202013912 D0 GB 202013912D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- yf17d
- cov
- attenuated
- vaccine against
- against sars
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2013912.7A GB202013912D0 (en) | 2020-09-04 | 2020-09-04 | Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 |
CA3168673A CA3168673A1 (en) | 2020-02-27 | 2021-03-01 | Coronavirus vaccines |
AU2021225362A AU2021225362A1 (en) | 2020-02-27 | 2021-03-01 | Coronavirus vaccines |
EP21706473.2A EP4110380A1 (en) | 2020-02-27 | 2021-03-01 | Coronavirus vaccines |
JP2022550759A JP2023516149A (en) | 2020-02-27 | 2021-03-01 | coronavirus vaccine |
US17/802,001 US20230241201A1 (en) | 2020-02-27 | 2021-03-01 | Coronavirus vaccines |
PCT/EP2021/055013 WO2021170869A1 (en) | 2020-02-27 | 2021-03-01 | Coronavirus vaccines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2013912.7A GB202013912D0 (en) | 2020-09-04 | 2020-09-04 | Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202013912D0 true GB202013912D0 (en) | 2020-10-21 |
Family
ID=72841335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2013912.7A Ceased GB202013912D0 (en) | 2020-02-27 | 2020-09-04 | Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202013912D0 (en) |
-
2020
- 2020-09-04 GB GBGB2013912.7A patent/GB202013912D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202010425D0 (en) | Combination vaccine | |
GB2592769B (en) | CpG-Adjuvanted SARS-CoV-2 virus vaccine | |
HK1250136A1 (en) | Vaccine compositions having improved stability and immunogenicity | |
GB202002166D0 (en) | Vaccine | |
GB201910794D0 (en) | Vaccine | |
GB202016954D0 (en) | Vaccine | |
GB202013912D0 (en) | Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 | |
GB202010479D0 (en) | Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 | |
GB202004825D0 (en) | Influenza vaccines | |
GB202119115D0 (en) | Vaccine | |
GB202118110D0 (en) | Vaccine | |
GB202114274D0 (en) | SARS-CoV-2 vaccine | |
GB202112149D0 (en) | Shigellla vaccine | |
GB202102677D0 (en) | Vaccine | |
GB202016165D0 (en) | Vaccine | |
GB202014719D0 (en) | Vaccine | |
GB202013541D0 (en) | Vaccine | |
GB202013534D0 (en) | Vaccine | |
GB202013253D0 (en) | Vaccine | |
GB202009402D0 (en) | Vaccine | |
GB202005878D0 (en) | Vaccine | |
GB202005880D0 (en) | Vaccine | |
GB202003292D0 (en) | Vaccine | |
GB202003289D0 (en) | Vaccine | |
GB202116831D0 (en) | Vaccines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |